IndiaMTF — home
Stock

Marksans Pharma — MTF Book

MARKSANS · Marksans Pharma Limited
Health Technology

Daily Margin Trading Facility book for Marksans Pharma across NSE and BSE, from 01 Aug 2017. All figures in ₹ crore, derived from exchange public disclosures.

What is Marksans Pharma’s MTF book?

Marksans Pharma Limited (MARKSANS) has ₹138 crore funded under Margin Trading Facility across NSE and BSE as of 23 Oct 2026 — 0.09% of India’s MTF book, ranking #274. Over 1M (the last 30 trading days) the funded value has fallen 1.6%, with the number of shares under margin down 4.4%.

Funded value
₹138 Cr
as of 23 Oct 2026
Rank in book
#274
2,209 days tracked
Share of book
0.09%
of the whole NSE + BSE book
Peak funded
₹586 Cr
on 03 Aug 2017
Largest single-day addition
+₹585 Cr
on 03 Aug 2017
Largest single-day unwind
−₹585 Cr
on 04 Aug 2017
Free-float market cap
₹7,300 Cr
full market cap ₹13,005 Cr · 56.1% free float · Small cap
MTF share of free float
1.98%
0.9× the median small cap · 2.3× the Health Technology median

Share of free float on margin, month by month

Shares under margin at each month-end as a share of free-float shares, using that month-end’s share count and the free-float filing public at the time. It counts shares, not value, so a price move does not move it by itself.

0.42%1.10%1.77%2.45%Feb 2024Oct 2026
View as table: share of free float on margin33 months
Month-end% of free float
23 Oct 20261.978%
30 Sep 20262.214%
31 Aug 20261.929%
31 Jul 20261.987%
30 Jun 20261.892%
29 May 20261.766%
30 Apr 20261.535%
30 Mar 20261.462%
27 Feb 20261.532%
30 Jan 20261.536%
31 Dec 20251.731%
28 Nov 20251.769%
31 Oct 20251.739%
30 Sep 20251.649%
29 Aug 20251.255%
31 Jul 20250.983%
30 Jun 20250.982%
30 May 20250.973%
30 Apr 20251.174%
28 Mar 20251.079%
28 Feb 20250.981%
31 Jan 20250.898%
31 Dec 20240.947%
29 Nov 20240.840%
31 Oct 20240.891%
30 Sep 20240.838%
30 Aug 20240.658%
31 Jul 20240.955%
28 Jun 20240.986%
31 May 20241.020%
30 Apr 20240.823%
28 Mar 20240.863%
29 Feb 20241.134%

Dated events

NSE & BSE split

How MARKSANS’s funded book divides across the two exchanges, as of 23 Oct 2026.
NSE
NSE ₹134 Cr · 96.5%BSE ₹5 Cr · 3.5%

MTF vs Price

Margin-funded outstanding for MARKSANS in ₹ crore against the closing price, adjusted for splits and bonuses. Each window uses the same reference date as the table below, so the two agree. Funded value moves with the price on its own, so the line under the chart reads the share count instead — that is what shows whether more stock is genuinely being borrowed against.
MTF book (₹ Cr)

Price and liquidity

Adjusted for splits and bonuses, so a change across a corporate action reflects the market rather than the share count.
Last close
₹286.90
as of 23 Oct 2026
Price, 1M
−13.1%
adjusted for splits and bonuses
Delivery, 20-day avg
42.7%
of traded volume actually settled
Sessions to unwind
7
of average deliverable volume
Shares under margin divided by average daily deliverable volume over the last 20 sessions.

Book, shares and price by window

Funded value moves with the price on its own, so the share count is what shows whether more stock is actually being borrowed against. The last column reads the two together.
WindowBook ΔBook %SharesPriceReading
1D−₹6−4.3%−3.9%
−2,03,935
−2.6%unwinding as it falls
10D−₹14−8.9%−7.8%
−4,26,336
−6.8%unwinding as it falls
1M−₹2−1.6%−4.4%
−2,31,778
−14.6%unwinding as it falls
3M+₹24+21.3%−1.6%
−82,013
+16.6%unwinding into strength
6M+₹64+86.5%+29.6%
+11,48,050
+48.5%building into strength
1Y+₹48+53.3%+13.2%
+5,87,209
+60.7%building into strength

Shares under margin

Number of shares funded via MTF over time (NSE + BSE combined).

Rank trajectory

Where MARKSANS has sat in the funded-value ranking each day (1 = most funded). Lower is more prominent.

MARKSANS — last 30 trading days

Combined NSE + BSE funded value, day-on-day change, share of the whole book, and rank. Newest first.
DateCombined (₹ Cr)Day Δ (₹ Cr)% of bookRank
23 Oct 2026138−₹60.09%274
22 Oct 2026145−₹20.09%265
21 Oct 2026146−₹30.09%263
19 Oct 2026150+₹00.10%262
16 Oct 2026149−₹10.10%262
15 Oct 2026150+₹00.10%260
14 Oct 2026149+₹00.10%259
13 Oct 2026149−₹10.10%257
12 Oct 2026151−₹10.10%256
09 Oct 2026152−₹00.10%252
08 Oct 2026152+₹30.10%253
07 Oct 2026149+₹10.10%255
06 Oct 2026148−₹00.09%259
05 Oct 2026148−₹40.09%258
01 Oct 2026152−₹40.10%248
30 Sep 2026156+₹60.10%243
29 Sep 2026150−₹40.10%251
28 Sep 2026154−₹20.10%246
25 Sep 2026156+₹20.10%241
24 Sep 2026154+₹40.10%245
23 Sep 2026149+₹70.10%255
22 Sep 2026142+₹30.09%267
21 Sep 2026140+₹20.09%274
18 Sep 2026137−₹10.09%284
17 Sep 2026138−₹00.09%280
16 Sep 2026138+₹20.09%282
15 Sep 2026136−₹30.09%286
11 Sep 2026139−₹60.09%282
10 Sep 2026144−₹00.09%265
09 Sep 2026145—0.09%265

MARKSANS within Health Technology

Ranked #11 of 61 funded Health Technology stocks, carrying 2.1% of that sector’s margin book. Its 1.98% of free float on margin is 2.2× the sector median of 0.90%. Nearest names by funded value:
#StockMTF book (₹ Cr)% of sector% of free floatBook, 1M
9NATCOPHARMNatco Pharma₹1742.6%1.80%−7.8%
10LUPINLupin Limited₹1452.2%0.27%−14.0%
11MARKSANSMarksans Pharma₹1382.1%1.98%−1.6%
12LENSKARTLenskart Solutions₹1332.0%0.15%+39.5%
13NEULANDLABNeuland Laboratories₹1241.8%0.72%+57.6%

All Health Technology stocks and how the sector has moved →

Disclaimer. Data sourced from daily margin trading disclosure provided by NSE and BSE. This website and page are meant for educational and information only — not investment advice. MTF is leveraged and can amplify losses. Rules, margins, rates and eligible-stock lists change; verify current details with your broker and SEBI/exchange circulars. IndiaMTF.com is not a SEBI-registered intermediary, broker, or investment adviser and has no affiliation with SEBI, NSE or BSE. Figures are reproduced from publicly disclosed exchange data, may be delayed or revised, and should be independently verified before any trading decision. Consult a SEBI-registered investment adviser before investing.